Rossari Biotech Limited announced earnings results for the third quarter ended December 30, 2020. For the third quarter, the company announced total revenue was INR 2,107.4 million compared to INR 1,624.67 million a year ago. Operating income was INR 277.64 million compared to INR 249.03 million a year ago. Net income was INR 216.01 million compared to INR 182.54 million a year ago. Basic earnings per share from continuing operations was INR 4.16 compared to INR 3.77 a year ago. Diluted earnings per share from continuing operations was INR 4.11 compared to INR 3.72 a year ago. For the nine months, total revenue was INR 4,974.3 million compared to INR 4,422.33 million a year ago. Operating income was INR 765.2 million compared to INR 880.59 million a year ago. Net income was INR 577.93 million compared to INR 501.54 million a year ago. Basic earnings per share from continuing operations was INR 11.24 compared to INR 10.36 a year ago. Diluted earnings per share from continuing operations was INR 11.12 compared to INR 10.21 a year ago.